BioLife Solutions Inc BLFS

Morningstar Rating
$24.54 +0.21 (0.86%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BLFS is trading at a 748% premium.
Price
$24.60
Fair Value
$45.14
Uncertainty
High
1-Star Price
$22.84
5-Star Price
$12.48
Economic Moat
Vypr
Capital Allocation

News

Trading Information

Previous Close Price
$24.33
Day Range
$24.2525.03
52-Week Range
$8.9226.73
Bid/Ask
$24.52 / $24.82
Market Cap
$1.13 Bil
Volume/Avg
211,498 / 335,511

Key Statistics

Price/Earnings (Normalized)
Price/Sales
9.11
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
414

Comparables

Valuation

Metric
BLFS
219A
300896
Price/Earnings (Normalized)
34.89
Price/Book Value
3.5210.21
Price/Sales
9.11105.9226.50
Price/Cash Flow
38.67
Price/Earnings
BLFS
219A
300896

Financial Strength

Metric
BLFS
219A
300896
Quick Ratio
1.6917.2815.24
Current Ratio
2.8618.2216.84
Interest Coverage
−34.50−1,951.591,119.23
Quick Ratio
BLFS
219A
300896

Profitability

Metric
BLFS
219A
300896
Return on Assets (Normalized)
−3.37%−25.34%28.38%
Return on Equity (Normalized)
−4.08%−27.01%30.49%
Return on Invested Capital (Normalized)
−3.31%−26.88%28.94%
Return on Assets
BLFS
219A
300896

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
PnpmbmfrjmQwyqz$171.3 Bil
Becton Dickinson & Co
BDX
TthfkfvlRfqclp$68.9 Bil
Alcon Inc
ALC
LthssmllCskdqyj$48.1 Bil
ResMed Inc
RMD
RlcjnttnbcSjpwyp$34.3 Bil
Coloplast AS ADR
CLPBY
NgknrzmdrZgwwg$28.7 Bil
West Pharmaceutical Services Inc
WST
HgjvzvqzTwt$21.5 Bil
The Cooper Companies Inc
COO
NkzlddrlzNcttkp$21.1 Bil
Hologic Inc
HOLX
FzjpqjkvJdxgxm$18.6 Bil
Baxter International Inc
BAX
DgmgpnkSvkpjtg$18.5 Bil
Align Technology Inc
ALGN
FncljwblYmxvyr$18.0 Bil

Sponsor Center